CTLA4 and neoplasm: In addition, a previous study reported that activation of the β-catenin signaling pathway or PTEN gene deletion were two oncogenic aberrations linked to ineffective T cell infiltration into tumor sites that promoted acquired resistance for patients with metastatic melanoma following combination with anti-CTLA-4 and anti-PD-1 therapy [28].